Navigation Links
Prix Galien USA to Launch a Health Care Dialogue Among World-Leading Innovators in Science, Economics and Biotech
Date:9/22/2009

Panelists to Explore the Role of Innovation in Global Public Health

NEW YORK, Sept. 22 /PRNewswire-USNewswire/ -- The committee for the Prix Galien USA, the equivalent to the Nobel Prize for pharmaceutical research and development, will host an unprecedented discussion of how innovative science and clinical research can improve health care across the U.S. and around the world.

The event will feature Walter Gilbert, M.D., founder of Biogen and a member of the Prix Galien USA committee; Leonard Bell, M.D., president and CEO of Alexion Pharmaceuticals; a patient living with the ultra-rare disease paroxysmal nocturnal hemoglobinuria (PNH); as well as the recipients of the 2009 Prix Galien Pro Bono Humanum Award, Barry Bloom, Ph.D., and Jeffrey Sachs, Ph.D. The event will be held at the American Museum of Natural History in New York City on September 30 at 2:30 p.m., preceding the 2009 Prix Galien USA gala awards ceremony.

Moderated by Prix Galien USA Committee Chair Gerald Weissmann, M.D., the discussion will examine the full spectrum of health and disease -- from the world's major pandemics to ultra-rare diseases -- and the role innovation plays in improving health care. Panelists will analyze the applications of basic biomedical science and economics that have been used to address the world's biggest problems and have the potential to improve human health and wellness.

WHEN: Wednesday, September 30, 2009, 2:30 p.m.

WHERE: The Portrait Room

American Museum of Natural History

Central Park West at 79th Street, New York

Enter through the Carriage Portico, under the main stairs

Contact Rachael Siefert at rsiefert@vancomm.com to RSVP for the event.

WHO: Dr. Gerald Weissmann, chair of the Prix Galien USA committee, will moderate the press event to feature:

  • Dr. Barry Bloom, Joan L. and Julius H. Jacobson Professor of Public Health, Harvard School of Public Health, 2009 Pro Bono Humanum Recipient
  • Dr. Jeffrey Sachs, director of the Earth Institute, Columbia University, 2009 Pro Bono Humanum Recipient
  • Dr. Walter Gilbert, Nobel Laureate and Prix Galien USA committee member
  • Dr. Leonard Bell, president and CEO of Alexion Pharmaceuticals, will address the critical need for ongoing medical innovation and access to therapies for patients with rare disorders and will be joined by a patient who will share their perspective on living with a rare disease.

The Prix Galien USA Award (www.prix-galien-usa.com) recognizes the technical, scientific and clinical research skills necessary to develop innovative medicines that improve the human condition, and is considered the industry's highest accolade for pharmaceutical research and development. The 11-member award committee includes seven Nobel Laureates, founders of major biotech companies and editors of world-renowned biology journal.

    CONTACT:
    Brandi Horton
    202-331-4323
    bhorton@vancomm.com


'/>"/>
SOURCE Prix Galien USA
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Prix Galien USA Now Accepting Nominations for Premiere Biopharmaceutical Industry Award
2. 2009 Prix Galien USA Now Accepting Nominations for Top Prize in Biopharmaceutical Research and Development
3. Prix Galien USA Recognizes Biotech, Pharmaceutical Industries for Innovative Medical Treatments
4. Prix Galien USA Welcomes Eighth Nobel Laureate to its Prestigious Award Committee
5. Abortion Opponents Launch Massive Grassroots Mobilization in 212 Cities
6. Childrens Hospitals and Clinics of Minnesota Launches H1N1 Outreach Effort with Minneapolis and Saint Paul Public Schools
7. Reportlinker Adds Pharmaceutical Outsourcing Opportunities Post-Launch: Contract Manufacturing and Contract Sales and Marketing, 3rd Edition Report
8. Video: Anthem Blue Cross and the California Governors Council on Physical Fitness and Sports Launch the Live Like a Champion Tour
9. NFL Network Launches 2009 National Keep Gym in School Campaign at New York City Middle School; Effort Will Give More U.S. Students Access to Quality Physical Education
10. Advantage Business Media Launches Enhanced Websites
11. Integrated Benefits Institute Launches Productivity Modeling Tools to Help Employers Estimate the Impact of Absent Employees
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2017)... ... June 23, 2017 , ... Ulster University, Magee Campus ... from 9 am to 3 pm to present to graduate students exciting new and ... an original curriculum project led by The Health Improvement Service of the Western Health ...
(Date:6/23/2017)... ... June 23, 2017 , ... Radabaugh & Associates, ... families and business owners in North Central West Virginia, is embarking on a ... differently abled residents in the region. , The Stepping Stones organization offers a ...
(Date:6/22/2017)... Indianapolis, IN (PRWEB) , ... June 22, 2017 ... ... employee benefits advisory organization, is pleased to welcome Whipple & Company as its ... on the clear purpose of balancing their clients’ risk while tailoring optimized benefit ...
(Date:6/22/2017)... , ... June 22, 2017 , ... ... awards for environmental excellence. Maryland Recycling Network has awarded the Baltimore VA Medical ... Outstanding Small Government Program Award for its efforts to promote waste reduction and ...
(Date:6/20/2017)... ... June 20, 2017 , ... ... that Claritas Capital, a Nashville-based private equity firm, has invested $3.35 million in ... for some time, and Claritas Capital offers the smart money, speed to market ...
Breaking Medicine News(10 mins):
(Date:6/8/2017)... 8, 2017  Less than a month ago, amateur ... 200,000 companies, including hospital networks, in over 150 countries. ... of the largest online extortion attempts ever recorded. With ... it is imperative that providers understand where the risks ... this — and many other very real cyber threats.  ...
(Date:6/7/2017)... GAITHERSBURG, Md. , June 7, 2017  Novavax, Inc., ... the second of two Phase 2 trials of its RSV ... women of child bearing age have been published in the ... this publication have been shared in prior scientific conferences). The ... trial in April 2014. Novavax is developing the RSV F ...
(Date:6/3/2017)... -- Eli Lilly and Company (NYSE: LLY ... 3 MONARCH 2 study showed that abemaciclib, a ... with fulvestrant, significantly improved progression-free survival (PFS) compared ... hormone-receptor-positive (HR+), human epidermal growth factor receptor 2-negative ... progressed after endocrine therapy (median PFS, 16.4 vs. ...
Breaking Medicine Technology: